4.3.4 Other antidepressant drugs
Mirtazapine
Mirtazapine 15mg orodispersible tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Mirtazapine 15mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Mirtazapine 30mg orodispersible tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Mirtazapine 30mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Mirtazapine 45mg orodispersible tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Mirtazapine 45mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Venlafaxine
Venlafaxine 150mg modified-release capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 150mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 37.5mg modified-release capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 37.5mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 37.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
Venlafaxine 75mg modified-release capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 75mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |
| Central nervous system | Social anxiety disorder |
| Central nervous system | Generalised anxiety disorder (GAD) |
Venlafaxine 75mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Depression |